RxDoctor Payments Data

Melanie Cogan, NP

Nurse Practitioner · Kennebunk, MENPI 1366631384

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Daiichi Sankyo Inc. at 26.6% of the total. Among nurse practitioner clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,114in general payments, 2019–2025

Across 38 payments — averaging $29.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Inc.$296
  • E.r. Squibb & Sons, L.L.C.$158
  • AbbVie$135
  • Pharmacyclics LLC, An Abbvie Company$125
  • Bristol Myers Squibb$125
  • Astellas Pharma US Inc$94
  • plus $180 from 8 others

What the payments were for

  • Food & beverage$1,114100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,114 in reported general payments places this provider in the 95th percentile of 740 nurse practitioner providers in Maine.

See all nurse practitioner providers in Maine

Medicare billing

Part B allowed, 2024
$299,881
Medicare patients
157
Services billed
11,055

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fentanyl11$1,180
Potassium Chloride17$1,052
Methylphenidate Hcl20$599
Tramadol Hcl11$537
Dexamethasone26$422
Hydroxyurea20$377
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$344
Mirtazapine12$258
Letrozole12$247
Ondansetron OdtOndansetron23$201
Levothyroxine Sodium14$168
Prednisone34$167
Anastrozole11$126
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine12$110
Acyclovir15$108

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Kennebunk

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →